IMMUCELL CORPORATION

ICCC
Delayed Quote. Delayed  - 10/21 03:33:18 pm
5.94USD +0.17%
Prev.5.9300
Open5.9400
High5.9400
Low5.7500
Volume3 684
Latest news
10/06
10/06
10/06
08/12
Chart IMMUCELL CORPORATION
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance6,076,356,13
Spread/Res.-2,1%-6,5%-3,1%
Spread/Supp.15%48%49%
Support5,164,024,00
Financials
Sales 2020 15,1 M - -
Net income 2020 -1,75 M - -
Net Debt 2020 - - -
P/E ratio 2020 -24,7x
Yield 2020 -
Capitalization 42,8 M 42,8 M -
Capi. / Sales 2020 2,83x
Capi. / Sales 2021 2,57x
Nbr of Employees -
Free-Float 70,4%
Company
ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-11-12 Earnings Release

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 1
Average target price 14,00 $
Last Close Price 5,93 $
Spread / Highest target 136%
Spread / Average Target 136%
Spread / Lowest Target 136%